Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Rhythm Pharmaceuticals Inc (NASDAQ: RYTM) was $59.97 for the day, up 2.51% from the previous closing price of $58.50. In other words, the price has increased by $2.51 from its previous closing price. On the day, 0.68 million shares were traded. RYTM stock price reached its highest trading level at $60.13 during the session, while it also had its lowest trading level at $57.585.
Ratios:
Our analysis of RYTM’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.34 and its Current Ratio is at 3.49. In the meantime, Its Debt-to-Equity ratio is 22.73 whereas as Long-Term Debt/Eq ratio is at 22.73.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Guggenheim on October 21, 2024, initiated with a Buy rating and assigned the stock a target price of $70.
On September 18, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $64.
On September 17, 2024, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $64.JMP Securities initiated its Mkt Outperform rating on September 17, 2024, with a $64 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 11 ’24 when Lee Jennifer Kayden sold 66,861 shares for $66.33 per share. The transaction valued at 4,434,882 led to the insider holds 972 shares of the business.
Shulman Joseph sold 13,281 shares of RYTM for $882,341 on Nov 11 ’24. The Chief Technical Officer now owns 0 shares after completing the transaction at $66.44 per share. On Nov 11 ’24, another insider, JENNIFER KAYDEN LEE, who serves as the Officer of the company, bought 66,861 shares for $67.33 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RYTM now has a Market Capitalization of 3685582336 and an Enterprise Value of 3641942528. For the stock, the TTM Price-to-Sale (P/S) ratio is 32.75 while its Price-to-Book (P/B) ratio in mrq is 328.51. Its current Enterprise Value per Revenue stands at 32.364 whereas that against EBITDA is -13.8.
Stock Price History:
Over the past 52 weeks, RYTM has reached a high of $68.58, while it has fallen to a 52-week low of $31.52. The 50-Day Moving Average of the stock is 13.70%, while the 200-Day Moving Average is calculated to be 31.40%.
Shares Statistics:
RYTM traded an average of 485.31K shares per day over the past three months and 1025050 shares per day over the past ten days. A total of 59.43M shares are outstanding, with a floating share count of 54.81M. Insiders hold about 10.82% of the company’s shares, while institutions hold 101.12% stake in the company. Shares short for RYTM as of 1730332800 were 8360239 with a Short Ratio of 17.23, compared to 1727654400 on 8234954. Therefore, it implies a Short% of Shares Outstanding of 8360239 and a Short% of Float of 20.57.
